Immunotherapy : towards engineered NK cell therapy : mRNA transfection of NK92 cells by photoporation with biodegradable polydopamine nanosensitizers
- Author
- Charlotte Hinnekens (UGent) , Aranit Harizaj (UGent) , Ilia Goemaere (UGent) , Stefaan De Smedt (UGent) , Bart Vandekerckhove (UGent) , Juan Fraire (UGent) and Kevin Braeckmans (UGent)
- Organization
- Keywords
- Cancer Research, Transplantation, Cell Biology, Genetics (clinical), Oncology, Immunology, Immunology and Allergy, CAR, Natural Killer Cells, photoporation
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 433.54 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HPRHXYZ7J29T3P8473Y57VWH
- MLA
- Hinnekens, Charlotte, et al. “Immunotherapy : Towards Engineered NK Cell Therapy : MRNA Transfection of NK92 Cells by Photoporation with Biodegradable Polydopamine Nanosensitizers.” CYTOTHERAPY, vol. 25, no. 6, 2023, pp. S228–S228, doi:10.1016/s1465-3249(23)00577-7.
- APA
- Hinnekens, C., Harizaj, A., Goemaere, I., De Smedt, S., Vandekerckhove, B., Fraire, J., & Braeckmans, K. (2023). Immunotherapy : towards engineered NK cell therapy : mRNA transfection of NK92 cells by photoporation with biodegradable polydopamine nanosensitizers. CYTOTHERAPY, 25(6), S228–S228. https://doi.org/10.1016/s1465-3249(23)00577-7
- Chicago author-date
- Hinnekens, Charlotte, Aranit Harizaj, Ilia Goemaere, Stefaan De Smedt, Bart Vandekerckhove, Juan Fraire, and Kevin Braeckmans. 2023. “Immunotherapy : Towards Engineered NK Cell Therapy : MRNA Transfection of NK92 Cells by Photoporation with Biodegradable Polydopamine Nanosensitizers.” In CYTOTHERAPY, 25:S228–S228. https://doi.org/10.1016/s1465-3249(23)00577-7.
- Chicago author-date (all authors)
- Hinnekens, Charlotte, Aranit Harizaj, Ilia Goemaere, Stefaan De Smedt, Bart Vandekerckhove, Juan Fraire, and Kevin Braeckmans. 2023. “Immunotherapy : Towards Engineered NK Cell Therapy : MRNA Transfection of NK92 Cells by Photoporation with Biodegradable Polydopamine Nanosensitizers.” In CYTOTHERAPY, 25:S228–S228. doi:10.1016/s1465-3249(23)00577-7.
- Vancouver
- 1.Hinnekens C, Harizaj A, Goemaere I, De Smedt S, Vandekerckhove B, Fraire J, et al. Immunotherapy : towards engineered NK cell therapy : mRNA transfection of NK92 cells by photoporation with biodegradable polydopamine nanosensitizers. In: CYTOTHERAPY. 2023. p. S228–S228.
- IEEE
- [1]C. Hinnekens et al., “Immunotherapy : towards engineered NK cell therapy : mRNA transfection of NK92 cells by photoporation with biodegradable polydopamine nanosensitizers,” in CYTOTHERAPY, 2023, vol. 25, no. 6, pp. S228–S228.
@inproceedings{01HPRHXYZ7J29T3P8473Y57VWH,
articleno = {{1032}},
author = {{Hinnekens, Charlotte and Harizaj, Aranit and Goemaere, Ilia and De Smedt, Stefaan and Vandekerckhove, Bart and Fraire, Juan and Braeckmans, Kevin}},
booktitle = {{CYTOTHERAPY}},
issn = {{1465-3249}},
keywords = {{Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy,CAR,Natural Killer Cells,photoporation}},
language = {{eng}},
number = {{6}},
pages = {{1032:S228--1032:S228}},
title = {{Immunotherapy : towards engineered NK cell therapy : mRNA transfection of NK92 cells by photoporation with biodegradable polydopamine nanosensitizers}},
url = {{http://doi.org/10.1016/s1465-3249(23)00577-7}},
volume = {{25}},
year = {{2023}},
}
- Altmetric
- View in Altmetric